98%
921
2 minutes
20
Equine influenza (EI) is a highly contagious viral respiratory disease affecting equids, with the potential of causing widespread outbreaks across Europe, the Americas, Asia, and other regions of the world. In Tunisia, in the spring of 2021, an EI virus outbreak occurred in a farm housing purebred Arabian horses that exhibited respiratory signs. This outbreak led to a national lockdown on horse movements and the cancellation of equestrian events. A total of 432 serum samples, collected from 2018 to 2021, were tested using ELISA competition assay. In addition, 100 Nasal swabs were collected during the 2021 outbreak and tested for the presence of EI via qRT-PCR. Five of these samples underwent full sequencing targeting hemagglutinin (HA) and neuraminidase (NA) genes. Phylogenetic and phylogeographic analyses were carried out on HA and NA gene sequences using Bayesian methods. Out of 432 serum samples, 80 tested positive, leading to an overall seroprevalence of 18.51 %, with the highest values recorded in 2018 and 2021. Complete sequences of the HA and NA genes identified the subtype as H3N8, belonging to the American lineage, Florida clade 1. Tunisian strains exhibited close genetic relationships with those from Algeria, the USA, France, Saudi Arabia, and the UK. Phylogeographic analysis reveals probable origin of the virus in Tunisia from the USA and France in 2017-2018. Our study highlights the critical need for continuous surveillance and molecular characterization of EI strains, particularly given their high transmissibility and potential for global dissemination.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.virol.2025.110655 | DOI Listing |
Vet Microbiol
August 2025
Equine Research Institute, Japan Racing Association, Tochigi, Shimotsuke, Japan.
In April and May 2025, outbreaks of equine influenza occurred for the first time in 17 years in Japan. Equine influenza virus (EIV) of the H3N8 subtype was mainly detected in heavy draft horse populations in Kumamoto Prefecture and the Tokachi area of Hokkaido. In total, 10 EIVs were isolated from infected horses and then were used for genetic and serological analyses.
View Article and Find Full Text PDFEquine Vet J
September 2025
College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of Korea.
Background: Despite routine vaccination, equine influenza outbreaks occur due to disparities of virus strains between vaccine and field, and immunity gaps between vaccinations.
Objectives: To evaluate whether a combination of adjuvants can enhance immune responses to equine influenza virus (EIV) vaccines.
Study Design: In vivo experimental study.
Prev Vet Med
August 2025
Trent University, 55 Thornton Road South, Oshawa, Ontario L1J 5Y1, Canada. Electronic address:
Horses are frequently transported, creating opportunities for the spread of pathogens. Disease transmission models for equine infectious diseases face limitations on their generalizability due to challenges in describing equine movement and the structure of their contact networks beyond simplistic assumptions. This study aimed to combine a stochastic, agent-based, SEIR model for equine influenza disease dynamics with an observed Ontario, Canada equine contact network structure to quantify the potential magnitude of equine influenza outbreaks in Ontario competition horses under different conditions.
View Article and Find Full Text PDFVet Med Int
August 2025
Humboldt Research Hub for Zoonotic Arboviral Diseases, University of Ibadan, Ibadan, Oyo, Nigeria.
African horse sickness (AHS) is a severe, infectious arthropod-borne disease of equids caused by the AHS virus (AHSV). It is endemic in Sub-Saharan Africa, and several sporadic outbreaks of the disease have been reported in Nigeria in the past 5 decades. Following a recent outbreak of the disease in Lagos State, this study was conducted to investigate the prevalence of (AHSV) antibodies in apparently healthy horses and some selected wildlife sampled in four geographical regions of Nigeria.
View Article and Find Full Text PDFPathogens
July 2025
Global Influenza Programme, World Health Organization, CH-1211 Geneva, Switzerland.
Zoonotic influenza viruses pose a significant and evolving public health threat. In response to the recent rise in H5N1 cross-species transmission, the World Health Organization (WHO) R&D Blueprint for Epidemics consultations have prioritized strengthening surveillance, candidate vaccines, diagnostics, and pandemic preparedness. Serological surveillance plays a pivotal role by providing insights into the prevalence and transmission dynamics of influenza viruses.
View Article and Find Full Text PDF